Gritstone bio Inc
General ticker "GRTS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $4.6M
Gritstone bio Inc does not follow the US Stock Market performance with the rate: -29.9%.
Estimated limits based on current volatility of 7.3%: low 0.02$, high 0.03$
Factors to consider:
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1.27$, 3.33$]
- 2024-12-30 to 2025-12-30 estimated range: [1.45$, 3.71$]
Financial Metrics affecting the GRTS estimates:
- Negative: Non-GAAP EPS, $ of -1.20 <= 0.12
- Negative: Operating profit margin, % of -89.52 <= 1.30
- Negative: Operating cash flow per share per price, % of -39.18 <= 2.49
- Negative: negative Net income
- Positive: Investing cash flow per share, $ of 0.89 > -0.12
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Interest expense per share, $ of 0.03 <= 0.15
- Negative: Industry earnings per price (median), % of -26.07 <= 1.37
- Negative: Industry operating cash flow per share per price (median), % of -23.21 <= 3.92
Short-term GRTS quotes
Long-term GRTS plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $48.21MM | $19.95MM | $16.34MM |
| Operating Expenses | $123.42MM | $140.37MM | $155.97MM |
| Operating Income | $-75.21MM | $-120.43MM | $-139.62MM |
| Non-Operating Income | $0.13MM | $0.74MM | $1.13MM |
| Interest Expense | $0.00MM | $1.24MM | $4.04MM |
| R&D Expense | $97.49MM | $111.40MM | $127.18MM |
| Income(Loss) | $-75.08MM | $-119.69MM | $-138.49MM |
| Profit(Loss) | $-75.08MM | $-119.69MM | $-138.49MM |
| Stockholders Equity | $216.09MM | $170.78MM | $51.85MM |
| Inventory | $15.73MM | $3.31MM | $0.00MM |
| Assets | $278.11MM | $240.75MM | $177.77MM |
| Operating Cash Flow | $-50.68MM | $-115.95MM | $-121.65MM |
| Investing Cash Flow | $-118.55MM | $-12.96MM | $102.34MM |
| Financing Cash Flow | $108.76MM | $83.10MM | $25.12MM |
| Earnings Per Share* | $-0.95 | $-1.24 | $-1.20 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.